RxNorm 605319
Saccharomyces boulardii Oral Powder
RxNorm Semantic Concepts
RxNorm semantic concepts for the RxCUI 605319 unique identifier include: Saccharomyces boulardii Oral Powder (2382710).
RxNorm Atom ID: 2382710 - Semantic Clinical Drug Form
Saccharomyces boulardii Oral Powder
- RXCUI:
- 605319 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 2382710 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Saccharomyces boulardii Oral Powder - Description of concept identifier
- Term Type (TTY):
- SCDF - Term type in source with name and description
- Term Type Name:
- Semantic Clinical Drug Form - Name of term type in source
- Term Type Description:
- Ingredient + Dose Form - Description of term type in source
- Code:
- 605319 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- 4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_240401F - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information - Source Content Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information - Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Patient Education
Saccharomyces Boulardii
What is it? Saccharomyces boulardii is a yeast believed to be a strain of Saccharomyces cerevisiae. It is likely effective for treating certain types of diarrhea.
Saccharomyces boulardii is called a "probiotic," a friendly organism that helps to fight off "bad" organisms that might cause diseases. Saccharomyces boulardii is different from other strains of Saccharomyces cerevisiae, commonly known as brewer's yeast and baker's yeast.
Saccharomyces boulardii is most commonly used for treating and preventing diarrhea, including rotaviral diarrhea in children. It has some evidence of use for other types of diarrhea, acne, and a digestive tract infection that can lead to ulcers. There is no good evidence to support using Saccharomyces boulardii for COVID-19.
[Learn More]
* Please review the disclaimer below.